PapersFlow Research Brief

CRISPR and Genetic Engineering
Research Guide

What is CRISPR and Genetic Engineering?

CRISPR and genetic engineering is the set of methods for making targeted, programmable changes to DNA in cells, exemplified by CRISPR-Cas systems that use guide RNAs to direct nucleases to specific genomic sequences for cutting and subsequent editing.

The CRISPR-Cas9 mechanism was established as a programmable, dual-RNA–guided DNA endonuclease in bacteria in "A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012). Practical genome editing in mammalian systems was rapidly operationalized and scaled to multiplex targets in "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013) and standardized as a laboratory protocol in "Genome engineering using the CRISPR-Cas9 system" (2013). The provided corpus for this topic contains 109,289 works (5-year growth rate: N/A).

109.3K
Papers
N/A
5yr Growth
2.9M
Total Citations

Research Sub-Topics

Why It Matters

CRISPR-based genetic engineering matters because it enables researchers to alter specific DNA sequences to test gene function, build engineered cell lines and organisms, and develop therapeutic strategies that require precise genomic modification. Foundational mechanistic work in "A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012) demonstrated that a dual-RNA guide can program a DNA endonuclease, creating a general route to sequence-targeted cutting that genetic engineering workflows can exploit. Translationally, "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013) demonstrated multiplex genome engineering, which is directly relevant to applications that require coordinated perturbation of multiple loci (for example, simultaneously editing several genes or regulatory elements in a single experiment). In practice, the availability of a detailed protocol in Ran et al. (2013) ("Genome engineering using the CRISPR-Cas9 system") supports reproducible deployment of CRISPR editing across laboratories, and downstream interpretation of genome-wide perturbation results is commonly paired with gene set enrichment workflows such as "Enrichr: a comprehensive gene set enrichment analysis web server 2016 update" (2016), which describes a web server used to analyze gene sets produced by genome-scale experiments.

Reading Guide

Where to Start

Start with "A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012) because it provides the conceptual mechanism—RNA-guided, programmable DNA cleavage—that underlies CRISPR-based genetic engineering.

Key Papers Explained

"A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012) establishes the programmable nuclease concept that makes CRISPR usable as an editing tool. That mechanistic basis is translated into practical genome engineering capabilities in "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013), which emphasizes scalability to multiple targets. For implementation details and reproducible execution, Ran et al. (2013) in "Genome engineering using the CRISPR-Cas9 system" provides protocol-level guidance that operationalizes the method in typical laboratories. For interpreting genome-scale outputs of perturbation experiments, "Enrichr: a comprehensive gene set enrichment analysis web server 2016 update" (2016) connects genetic engineering results to pathway- and gene-set–level interpretation. For core enabling methods used throughout genetic engineering pipelines (construction and validation), "Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase" (1988) provides the PCR foundation that underpins cloning, genotyping, and edit verification.

Paper Timeline

100%
graph LR P0["Primer-Directed Enzymatic Amplif...
1988 · 17.1K cites"] P1["The C. elegans heterochronic gen...
1993 · 12.7K cites"] P2["Potent and specific genetic inte...
1998 · 15.1K cites"] P3["One-step inactivation of chromos...
2000 · 14.9K cites"] P4["Induction of Pluripotent Stem Ce...
2006 · 26.1K cites"] P5["A Programmable Dual-RNA–Guided D...
2012 · 16.6K cites"] P6["Multiplex Genome Engineering Usi...
2013 · 15.3K cites"] P0 --> P1 P1 --> P2 P2 --> P3 P3 --> P4 P4 --> P5 P5 --> P6 style P4 fill:#DC5238,stroke:#c4452e,stroke-width:2px
Scroll to zoom • Drag to pan

Most-cited paper highlighted in red. Papers ordered chronologically.

Advanced Directions

Within the constraints of the provided paper list, the main frontier is scaling from single-locus edits to robust multiplex perturbation and standardized execution across labs, anchored by "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013) and "Genome engineering using the CRISPR-Cas9 system" (2013). Another active direction is strengthening inference from large CRISPR perturbation experiments by pairing gene perturbation outputs with systematic enrichment analysis workflows described in "Enrichr: a comprehensive gene set enrichment analysis web server 2016 update" (2016).

Papers at a Glance

In the News

New funding brings personalized CRISPR cures closer to children with rare diseases

Jul 2025 news-medical.net Chan Zuckerberg InitiativeJul 8 2025

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available. Today, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics ...

World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children’s Hospital of Philadelphia

Sep 2025 chop.edu The Children's Hospital of Philadelphia

### $14M NIH grant funds gene-editing research for rare metabolic diseases at Penn and CHOP Researchers aim to develop personalized therapies for urea cycle disorders and other genetic conditions u...

A baby gets the world's first personalized CRISPR therapy

May 2025 cen.acs.org Priyanka Runwal

extremely small. Meanwhile, the Accelerating Medicines Partnership Program Bespoke Gene Therapy Consortium, a public-private partnership, is working toward[streamlining regulatory requirements and ...

World’s first personalized CRISPR therapy given to baby with genetic disease

May 2025 nature.com Ledford, Heidi

Treatment seems to have been effective, but it is not clear whether such bespoke therapies can be widely applied. By * Heidi Ledford 1. Heidi Ledford View author publications

CRISPR Clinical Trials: A 2025 Update

Jul 2025 innovativegenomics.org Hope Henderson

The best: a year and half ago, we saw the first-ever approval of CRISPR-based medicine: Casgevy, a cure for sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TBT). Since then, 5...

Code & Tools

Recent Preprints

Latest Developments

Recent developments in CRISPR and genetic engineering research include the creation of a CRISPR-Cas-based system to edit epigenetic marks in mouse sperm, enabling direct investigation of gene regulation (CMN Weekly, 9 January 2026), the successful administration of personalized in vivo CRISPR therapies in patients, and advances toward platform therapies (Innovative Genomics Institute, July 2025), as well as the development of next-generation CRISPR systems that enable highly precise editing without DNA double-strand breaks (PMC, 2026). Additionally, breakthroughs include turning genes on without cutting DNA by removing chemical tags, and expanding the repertoire of CRISPR-associated proteins through AI-designed systems (ScienceDaily, 5 January 2026; Nature, 30 July 2025).

Frequently Asked Questions

What is the minimal molecular principle that makes CRISPR-Cas9 programmable for genome editing?

"A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012) demonstrated that a DNA endonuclease can be directed to specific DNA sequences by RNA guides. In that framework, the guide RNA provides sequence complementarity that determines the target, making the nuclease programmable in a sequence-specific way.

How did CRISPR move from a mechanistic finding to a practical genome engineering method?

"A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012) established RNA-guided DNA cleavage as a programmable activity. "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013) then demonstrated genome engineering with CRISPR/Cas systems in a way that supports targeting multiple loci, and "Genome engineering using the CRISPR-Cas9 system" (2013) provided a procedural protocol for implementing the system.

Which paper should I cite for multiplexing—editing more than one genomic target in the same experiment?

"Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013) is the most direct citation in the provided list for multiplex genome engineering. It specifically frames CRISPR/Cas systems as enabling multiplex targeting, which is central when designing experiments that perturb multiple genes or sites.

How is CRISPR-based genetic engineering commonly connected to downstream functional interpretation of results?

Genome editing experiments often output gene lists (for example, genes whose perturbation changes a phenotype), and those lists are frequently interpreted with enrichment analysis. "Enrichr: a comprehensive gene set enrichment analysis web server 2016 update" (2016) describes a web server used for gene set enrichment analysis, supporting interpretation of gene sets generated by genome-wide experiments.

Which enabling methods outside CRISPR are repeatedly used in genetic engineering workflows and appear in this literature set?

DNA amplification is a core enabling method for constructing and validating edited alleles, and "Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase" (1988) describes PCR using a thermostable polymerase. Targeted gene disruption in bacteria is also a foundational engineering capability described in "One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products" (2000), which uses PCR products and recombination to disrupt chromosomal genes.

What is the current scale of the CRISPR and genetic engineering literature in the provided dataset?

The provided dataset reports 109,289 works for the topic "CRISPR and Genetic Engineering". The 5-year growth rate is listed as N/A in the provided data.

Open Research Questions

  • ? How can multiplex CRISPR designs (as framed in "Multiplex Genome Engineering Using CRISPR/Cas Systems" (2013)) be optimized to maintain per-target efficacy while minimizing unintended interactions among simultaneous edits?
  • ? What experimental and analytical standards should be adopted to make CRISPR editing workflows maximally reproducible across laboratories, building on procedural guidance in Ran et al. (2013) ("Genome engineering using the CRISPR-Cas9 system")?
  • ? How should gene set enrichment analysis outputs (as described in "Enrichr: a comprehensive gene set enrichment analysis web server 2016 update" (2016)) be best integrated with CRISPR perturbation data to distinguish direct genetic effects from downstream pathway responses?
  • ? Which mechanistic constraints of RNA-guided endonuclease targeting, as established in "A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (2012), most strongly limit editing specificity in complex genomes, and how can experiments be designed to quantify those limits?
  • ? How can PCR-based validation strategies (as described in "Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase" (1988)) be standardized to reliably confirm intended edits and detect heterogeneous editing outcomes in mixed cell populations?

Research CRISPR and Genetic Engineering with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching CRISPR and Genetic Engineering with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.